Research progress on the role and molecular mechanism of PRDX4 in malignant tumors

Li Xuelian1, Shang Panfeng1, Zhang Xingxing1

  • 1The Second Clinical College of Lanzhou University, Lanzhou, China.

Bulletin Du Cancer
|March 29, 2025
PubMed

Insights

Peroxiredoxin IV (PRDX4), an antioxidant enzyme, is vital for cellular processes and shows potential as a cancer treatment target. Further research is needed to clarify its complex roles in various malignant tumors.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Peroxiredoxin IV (PRDX4) is a key antioxidant enzyme within the Peroxiredoxin (PRDX) family.
  • PRDX4 regulates critical cellular functions including protein folding, DNA damage response, inflammation, and tumorigenesis.
  • It acts as a regulatory factor in redox signaling pathways, controlling reactive oxygen species (ROS) levels via oxidative defense.

Purpose of the Study:

  • To review the multifaceted roles of PRDX4 in the development and progression of malignant tumors.
  • To elucidate the molecular mechanisms underlying PRDX4's functions in various cancer types.
  • To provide insights for future research directions targeting PRDX4 in cancer therapy.

Main Methods:

  • Literature review of recent studies on PRDX4.
  • Analysis of PRDX4's involvement in cellular redox homeostasis.
  • Examination of PRDX4's association with tumorigenesis and cancer progression.

Main Results:

  • PRDX4's antioxidant activity is crucial for cellular defense against oxidative stress.
  • Evidence suggests PRDX4's involvement in multiple stages of tumorigenesis.
  • Its precise functions and mechanisms in different cancers remain incompletely understood and debated.

Conclusions:

  • PRDX4 is implicated in critical cellular processes relevant to cancer.
  • Its role as a potential therapeutic target in oncology warrants further investigation.
  • Comprehensive understanding of PRDX4's biological functions and molecular mechanisms in tumors is essential.